Generation Bio IPO

Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases.

Register for Details

For more details on financing and valuation for Generation Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Generation Bio's ticker symbol?


What is Generation Bio's stock price?

4.03 as of 5/25/23

Learn more about Generation Bio

Forge green plus iconForge green minus icon

What is Generation Bio funding to date?

Generation Bio has raised $125.37MM.
Forge green plus iconForge green minus icon

When was Generation Bio founded?

Generation Bio was founded in 2016.